Pioglitazone: cardiovascular effects in prediabetic patients.
about
Genetics of type 2 diabetes: insights into the pathogenesis and its clinical application.Pharmacogenetics and personalized treatment of type 2 diabetesCombining a dipeptidyl peptidase-4 inhibitor, alogliptin, with pioglitazone improves glycaemic control, lipid profiles and beta-cell function in db/db mice.Pioglitazone: A review of analytical methods.
P2860
Pioglitazone: cardiovascular effects in prediabetic patients.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Pioglitazone: cardiovascular effects in prediabetic patients.
@ast
Pioglitazone: cardiovascular effects in prediabetic patients.
@en
type
label
Pioglitazone: cardiovascular effects in prediabetic patients.
@ast
Pioglitazone: cardiovascular effects in prediabetic patients.
@en
prefLabel
Pioglitazone: cardiovascular effects in prediabetic patients.
@ast
Pioglitazone: cardiovascular effects in prediabetic patients.
@en
P2093
P1476
Pioglitazone: cardiovascular effects in prediabetic patients.
@en
P2093
Katsufumi Mizushige
Takahisa Noma
Teppei Tsuji
P304
P577
2002-01-01T00:00:00Z